Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine in metastatic cancer of unknown primary
NCT00357630Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Jun 2006
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in carcinoma of unknown primary (CUP), sponsored by Eastern Cooperative Oncology Group. Started Jun 2006; status: completed.
02
Drugs
gemcitabine
03
Conditions
carcinoma of unknown primary (CUP)
Beyond the preview
Go deeper on NCT00357630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00357630.